menu
    • menu

    Company profile for Elysium Therapeutics

    NEW Drugs in Dev: 3
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Elysium is a rising biopharmaceutical firm pioneering enhanced safety standards in the opioid sector through the development of SMART™ (Safer Medicines Alleviate Risks and Trauma) products. These innovative medications aim to mitigate the limitations and hazards linked with opioids and overdose rescue agents, thereby alleviating suffering from opioid-use disorder, opioid overdose, and acute pain. The company's flagship SMART...
    Elysium is a rising biopharmaceutical firm pioneering enhanced safety standards in the opioid sector through the development of SMART™ (Safer Medicines Alleviate Risks and Trauma) products. These innovative medications aim to mitigate the limitations and hazards linked with opioids and overdose rescue agents, thereby alleviating suffering from opioid-use disorder, opioid overdose, and acute pain. The company's flagship SMART opioid product candidate, oral-overdose protected (O2P™) hydrocodone, is undergoing development for the management of moderate-to-severe acute pain.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Elysium TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1201 East Market Street, Suite 604, Akron, OH 44305, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.elysiumrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/elysium-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elysium Therapeutics Secures $7.5M To Advance Oral Fentanyl
    Elysium Therapeutics Secures $7.5M To Advance Oral Fentanyl

    28 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-raises-7-5-million-safe-round-to-accelerate-development-of-novel-rescue-therapy-designed-to-specifically-combat-oral-fentanyl-overdose-302671914.html

    PR NEWSWIRE
    28 Jan 2026
    Share Share
    Elysium' Pre-IND Meeting with FDA for Oral Fentanyl Overdose Tech
    Elysium' Pre-IND Meeting with FDA for Oral Fentanyl Overdose Tech

    20 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-completes-pre-ind-meeting-with-fda-for-first-ever-technology-designed-to-combat-oral-fentanyl-overdose-302533882.html

    PR NEWSWIRE
    20 Aug 2025
    Share Share
    Elysium Therapeutics Investor Webcast Highlights Fentanyl Rebound
    Elysium Therapeutics Investor Webcast Highlights Fentanyl Rebound

    11 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-investor-webcast-highlights-fentanyl-rebound-as-key-challenge-in-reducing-opioid-overdose-hospitalizations-and-deaths-302479378.html

    PR NEWSWIRE
    11 Jun 2025
    Share Share
    Elysium Therapeutics at 2025 BIO Convention on Fentanyl Rebound
    Elysium Therapeutics at 2025 BIO Convention on Fentanyl Rebound

    05 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-to-participate-in-the-2025-bio-international-convention-to-discuss-challenge-of-fentanyl-rebound-and-rescue-medication-designed-for-synthetic-opioids-302473757.html

    PR NEWSWIRE
    05 Jun 2025
    Share Share
    Elysium Investor Webcast on SOOPR™ Program &
    Elysium Investor Webcast on SOOPR™ Program & "Fentanyl Rebound"

    12 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-to-host-investor-webcast-highlighting-soopr-program-and-the-need-to-address-fentanyl-rebound-as-key-challenge-in-the-opioid-overdose-epidemic-302452576.html

    PR NEWSWIRE
    12 May 2025
    Share Share
    Elysium Therapeutics Develops Oral Fentanyl Overdose Rescue Tech
    Elysium Therapeutics Develops Oral Fentanyl Overdose Rescue Tech

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/elysium-therapeutics-announces-development-of-overdose-rescue-technology-specifically-designed-for-oral-fentanyl-302421250.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search